Barron's Logo

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/news/blood-clots-should-be-listed-as-rare-johnson-johnson-side-effect-ema-01618929319

Blood Clots Should Be Listed As Rare Johnson & Johnson Side Effect: EMA

By AFP - Agence France Presse
  • Order Reprints
  • Print Article

Blood clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU's drug watchd...

Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.